Edition:
United States

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.38USD
14 Dec 2017
Change (% chg)

$-0.01 (-3.64%)
Prev Close
$0.39
Open
$0.38
Day's High
$0.39
Day's Low
$0.36
Volume
30,864
Avg. Vol
50,645
52-wk High
$2.85
52-wk Low
$0.36

Latest Key Developments (Source: Significant Developments)

Akers Biosciences says Q3 revenue rose 10 pct to $675,800
Wednesday, 15 Nov 2017 07:00am EST 

Nov 15 (Reuters) - Akers Biosciences Inc -:Akers Biosciences announces Q3 2017 earnings.Q3 revenue rose 10 percent to $675,800.Akers Biosciences Inc - ‍Q3 gross margin reduced to 52%​.  Full Article

Akers Biosciences Inc Q2 revenue up 25 pct
Tuesday, 15 Aug 2017 07:00am EDT 

Aug 15 (Reuters) - Akers Biosciences Inc ::Akers Biosciences announces Q2 2017 earnings.Q2 revenue rose 25 percent to $1.2 million.Qtrly loss before income tax reduced by 34% to $666,647.  Full Article

Akers Biosciences Q2 revenue $1.2 million
Thursday, 3 Aug 2017 11:39am EDT 

Aug 3 (Reuters) - Akers Biosciences Inc ::Akers Biosciences announces second quarter trading update.Q2 revenue $1.2 million.  Full Article

Akers Biosciences reports 10 pct fall in Q1 revenue
Tuesday, 16 May 2017 07:00am EDT 

May 16 (Reuters) - Akers Biosciences Inc -:Akers Biosciences announces Q1 2017 earnings.Q1 revenue fell 10 percent to $667,300.Qtrly total revenue $667,250 versus $738,023.Akers Biosciences Inc - expect to see growth in flagship pifa heparin pf/4 rapid assay product line for the year.  Full Article

Akers Biosciences reports earnings for fiscal year 2016
Tuesday, 11 Apr 2017 07:00am EDT 

Akers Biosciences Inc : Akers Biosciences reports earnings for fiscal year 2016 .Akers Biosciences - Expect 2017 to be characterized by further growth in flagship PIFA Heparin PF/4 rapid assay product line, sales of rapid cholesterol test.  Full Article

Empery Asset Management reports 8.45 pct passive stake in Akers Biosciences
Friday, 7 Apr 2017 02:32pm EDT 

Akers Biosciences Inc :Empery Asset Management LP reports 8.45 percent passive stake in Akers Biosciences Inc, as of March 30, 2017 - sec filing.  Full Article

Akers Biosciences files for non-timely 10-K - SEC filing
Friday, 31 Mar 2017 04:13pm EDT 

Akers Biosciences Inc : Akers Biosciences Inc files for non-timely 10-K - SEC filing .Akers Biosciences Inc - unable to file 10-K due to delay experienced in completing financial statements and other disclosures in the annual report.  Full Article

Akers Biosciences announces a $2 million private placement
Thursday, 30 Mar 2017 04:25pm EDT 

Akers Biosciences Inc : Akers Biosciences announces a $2 million private placement .Akers Biosciences Inc - Akers Bio will issue 1.4 million shares at a price of $1.40 per share.  Full Article

Akers Biosciences reports preliminary unaudited earnings highlights for fiscal year 2016
Thursday, 30 Mar 2017 08:30am EDT 

Akers Biosciences Inc : Akers Biosciences reports preliminary unaudited earnings highlights for fiscal year 2016 .Akers Biosciences Inc - "expect 2017 to be characterized by further growth in our flagship PIFA heparin PF/4 rapid assay product line".  Full Article

Akers Biosciences allowed U.S. patent for Akers Wellness tests cartridge
Thursday, 16 Feb 2017 07:00am EST 

Akers Biosciences Inc - : US patent,trademark office allowed patent covering akers bio's proprietary cartridge for optical scanning device .Akers Wellness intends to start marketing oxichek™ through direct-to-consumer channels during 2017.  Full Article

BRIEF-Akers Biosciences - Accutest Solutions secured new channel partner for sales​

* Akers Biosciences - ‍announces Accutest Solutions a distributor of Akers Bio's breathscan alcohol detector in UK, secured new channel partner for sales​